Evidence map›Paper›PMID 38510968›Full record

ArticleFrontiers in cellular and infection microbiology2024

Fluoroquinolone resistance in complicated urinary tract infections: association with the increased occurrence and diversity of

Isidro García-Meniño, Vanesa García, Pilar Lumbreras-Iglesias, Javier Fernández, Azucena Mora

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 14 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Microbiology spectrum · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Emergence of Carbapenem-Resistant UropathogenicPathogens (Basel, Switzerland) · 2024
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Isidro García-Meniño *Laboratorio de Referencia de Escherichia coli (LREC), Dpto. de Microbioloxía e Parasitoloxía, Universidade de Santiago de Compostela (USC), Lugo, Spain.
Vanesa García *Laboratorio de Referencia de Escherichia coli (LREC), Dpto. de Microbioloxía e Parasitoloxía, Universidade de Santiago de Compostela (USC), Lugo, Spain.
Pilar Lumbreras-IglesiasServicio de Microbiología, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.
Javier Fernández *Servicio de Microbiología, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.
Azucena Mora *Laboratorio de Referencia de Escherichia coli (LREC), Dpto. de Microbioloxía e Parasitoloxía, Universidade de Santiago de Compostela (USC), Lugo, Spain.
Instituto de Investigación Sanitaria de Santiago · ESInstituto de Investigación Sanitaria del Principado de Asturias · ESUniversidad de Oviedo · ESUniversidade de Santiago de Compostela · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Urinary tract infections (UTIs) are one of the leading causes of multidrug-resistance (MDR) spread and infection-related deaths. Methods: 154 non-duplicated Results: Most cUTI isolates belonged to phylogroup B2 (72.1%) and met the uropathogenic (UPEC) status (69.5%) (≥3 of Conclusion: We proved here that non-lactose fermenting screening, together with the detection of O25b (

Indexed as

Escherichia coli InfectionsUrinary Tract InfectionsAnti-Bacterial Agentsbeta-LactamasesEscherichia coliFluoroquinolonesHumansProspective StudiesAnti-Bacterial Agentsbeta-LactamasesFluoroquinolonescomplicated urinary tract infection (cUTI)fluoroquinolone resistance (FQR)ST1193ST131ST9126uropathogenic Escherichia coli (UPEC)

Identifiers

PMID38510968
PMCPMC10953827
OpenAlexW4392195422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.